Plant-Based Investment Corp.

Plant-Based Investment Corp. was a Canadian public investment company rather than an operating biotech or pharmaceutical developer. Its stated mandate was to generate shareholder returns by investing in public and private companies tied to plant-based sectors, including cannabis, fungi including medicinal and psychedelic applications, superfoods, organic ingredients, and related wellness clinics and treatment centers. The company was listed on the Canadian Securities Exchange under the symbol PBIC and also traded in the U.S. on OTC markets as CWWBF. Public disclosures in 2023 indicate significant financial distress, including a cease-trade-related filing delay and initiation of CCAA protection proceedings, and the CSE now shows the company as delisted. It does not appear to have had a proprietary drug pipeline, therapeutic programs, or clinical-stage assets of its own.